Rezolute (RZLT) Cash from Operations (2010 - 2026)
Rezolute (RZLT) reported Cash from Operations of 13689000.0 for Q1 2026, up 21.33% on a YoY basis from 11282677.28 in Q1 2025, and up 32.9% sequentially from 20400000.0 in Q4 2025.
Rezolute (RZLT) Cash from Operations (2010 - 2026) Analysis & Trends
Rezolute (RZLT) has 17 years of Cash from Operations data on file, last reported at 13689000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 21.33% year-over-year to 13689000.0; the trailing twelve-month figure through Mar 2026 stood at 73509000.0 (down 12.05% YoY), and the FY2025 full-year result was 69100000.0, down 20.45% from the prior year.
- Cash from Operations advanced to 13689000.0 in Q1 2026, from 20400000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 7493000.0 in Q4 2022 to a low of 22020000.0 in Q2 2025.
- A 5-year average of 14618588.24 and a median of 13968000.0 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 158.81% in 2022 and grew 21.33% in 2026, its largest moves.
- Tracing RZLT's Cash from Operations over 5 years: stood at 7493000.0 in 2022, then sank by 73.76% to 13020000.0 in 2023, then decreased by 4.96% to 13666000.0 in 2024, then sank by 49.28% to 20400000.0 in 2025, then soared by 32.9% to 13689000.0 in 2026.
- Business Quant data shows RZLT's Cash from Operations at 13689000.0 in Q1 2026, 20400000.0 in Q4 2025, and 17400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | -13.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.69 Mn |
| Mar 31, 2026 | -13.69 Mn |
| Dec 31, 2025 | -20.40 Mn |
| Dec 31, 2025 | -20.40 Mn |
| Sep 30, 2025 | -17.40 Mn |
| Sep 30, 2025 | -17.40 Mn |
| Jun 30, 2025 | -22.02 Mn |
| Jun 30, 2025 | -22.02 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -13.67 Mn |
| Dec 31, 2024 | -13.67 Mn |
| Sep 30, 2024 | -16.01 Mn |
| Sep 30, 2024 | -16.01 Mn |
| Jun 30, 2024 | -18.52 Mn |
| Jun 30, 2024 | -18.52 Mn |
| Mar 31, 2024 | -15.24 Mn |
| Mar 31, 2024 | -15.24 Mn |
| Dec 31, 2023 | -13.02 Mn |
| Dec 31, 2023 | -13.02 Mn |